MICHAEL TILLER — Lobbyist Profile | Poliscope

MICHAEL TILLER

Filings

Clients

Firms

Years active

2012–2018

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
COMPRESSED GAS ASSOCIATION, INC.	30	2012–2018

Lobbying firms

Firm	Filings	Years
COMPRESSED GAS ASSOCIATION, INC.	30	2012–2018

Bills explicitly cited in this lobbyist’s assigned issues (5)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

S. 3187

Federal Aviation Administration Extension Act of 2010

Client: COMPRESSED GAS ASSOCIATION, INC. · Firm: COMPRESSED GAS ASSOCIATION, INC.

Open original LDA filing ↗

Cited source text

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

S. 3187

Federal Aviation Administration Extension Act of 2010

Client: COMPRESSED GAS ASSOCIATION, INC. · Firm: COMPRESSED GAS ASSOCIATION, INC.

Open original LDA filing ↗

Cited source text

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

Original LDA source filings (30)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2018 · fourth_quarter · Q4

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2018 · third_quarter · Q3

Firm income: —

Source: Senate LDA

Show 26 more original filings

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2017 · fourth_quarter · Q4

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144); Quality Metrics.

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2017 · third_quarter · Q3

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144); Quality Metrics.

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2017 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144); Quality Metrics.

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2017 · first_quarter · Q1

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2016 · fourth_quarter · Q4

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2016 · third_quarter · Q3

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2016 · second_quarter · Q2

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2016 · first_quarter · Q1

Firm income: —Client expense: $60,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2015 · fourth_quarter · Q4

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2015 · third_quarter · Q3

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2015 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2015 · first_quarter · Q1

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2014 · fourth_quarter · Q4

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2014 · third_quarter · Q3

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2014 · second_quarter · Q2

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2014 · first_quarter · Q1

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · fourth_quarter · Q4

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Implementation of the Food & Drug Administration Safety & Innovation Act, Title II, Subtitle B, Medical Gas Product Regulation (P.L. 112-144).

Filing targets: Food & Drug Administration (FDA)

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · first_quarter · 1A

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · second_quarter · 2A

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · third_quarter · Q3

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2013 · first_quarter · Q1

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2012 · first_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2012 · first_quarter · Q1

Firm income: —Client expense: $70,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2012 · second_quarter · Q2

Firm income: —Client expense: $100,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases.

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

COMPRESSED GAS ASSOCIATION, INC. via COMPRESSED GAS ASSOCIATION, INC.

2012 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

S. 3187, Title II Subtitle B, Medical Gas Product Regulation, FDA approval and regulation of medical gases